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INTRODUCTION
Cervical cancer is the second most common cancer
among women worldwide.1 Worldwide, cervical can-
cer claims the lives of 231,000 women annually.2 It
is an important public health problem among adult
women in large areas of the developing world where
an estimated 80% of new cases arise.1,2 This cancer
accounts for only 3.6% of new cancer in developed
countries. The incidence is lower in developed coun-
tries because well-developed screening programs had
led to an important decline of cervix cancer incidence
and mortality rates during 40 last years.3 Despite ad-
Abstract
Objective: To review the distribution of age, stage at presenta-
tion, and histology of cervical cancer at Dr. Cipto Mangunkusumo
Hospital.
Materials and methods: This cross sectional study involved
2297 subjects with cervical cancer at Dr. Cipto Mangunkusumo
Hospital and registered at the Cancer Registration Information Sys-
tem during 5 years period from January 2006 to December 2010.
Histotype was confirmed by histopathology examination. The Inter-
national Federation of Gynecology and Obstetrics (FIGO) classifi-
cation was used to stage the disease.
Result: The mean age of cervical cancer patients was 51.42
years old (SD 9.694, range 21 - 85). The highest incidence was in
35 - 64 years (87.3%), with the peak incidence in 40 - 59 years
(71.3%). There were 0.4 % patients identified at stage IA1, 0.1% at
stage IA2, 7.3% at stage IB1, 4.9% at stage IB2, 10.5% at stage IIA,
17.3% at IIB, 1.7% at stage IIIA, 50.2% at stage IIIB, 4.3% at stage
IVA, 3.2% at stage IVB. Of the 2297 patients, 70.2% had epider-
moid carcinoma, 15.1% had adenocarcinoma, 10.2% had adeno-
squamous, 0.6% had clear cell, 3.9% had other types.
Conclusion: A large proportion of cervical cancer (76.7%) pre-
sented in advanced stage (≥ stage IIB). The highest incidence
(57.8%) was in the age range 45 - 59 years. Squamous cell carci-
noma is the most frequent histopathology type (70.2%), followed by
adenocarcinoma (15.1%) and adenosquamosa (10.2%). A lack of ef-
fective screening programs aimed at detecting and treating pre-
cancerous conditions is a key reason for the high incidence of cer-
vical cancer at advanced stage.
[Indones J Obstet Gynecol 2011; 35-1: 21-4]
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Abstrak
Tujuan: Untuk mengetahui distribusi usia, stadium, dan jenis
histopatologi kanker serviks di Rumah Sakit Dr. Cipto Mangun-
kusumo.
Bahan dan cara kerja: Penelitian secara retrospektif melibat-
kan 2297 subjek yang didiagnosis kanker serviks di Rumah Sakit Dr.
Cipto Mangunkusumo dan teregistrasi dalam Cancer Registration
Information System selama 5 tahun mulai dari Januari 2006 sampai
Desember 2010. Jenis histologi dikonfirmasi dengan pemeriksaan
histopatologi. Klasifikasi stadium menggunakan klasifikasi dari The
International Federation of Gynecology and Obstetrics (FIGO).
Hasil: Rerata usia pasien dengan kanker serviks adalah 51,42
tahun (SD 9,694; 21 - 85 tahun). Sebagian besar insidens terjadi
pada kelompok usia 35 - 64 tahun (87,3%), dengan puncak pada
kelompok usia 40 - 59 tahun (71,3%). Pasien terdiagnosis pada sta-
dium IA1 sebesar 0,4%, stadium IA2 sebesar 0,1%, stadium IB1 se-
besar 7,3%, stadium IB2 sebesar 4,9%, stadium IIA sebesar 10,5%,
stadium IIB sebesar 17,3%, stadium IIIA sebesar 1,7%, stadium
IIIB sebesar 50,2%, stadium IVA sebesar 4,3%, stadium IVB sebe-
sar 3,2%. Sebaran stadium didapatkan data sebagai berikut: karsi-
noma sel skuamosa 70,2%, adenokarsinoma 15,1%, adenoskuamo-
sa 10,2%, clear cell carcinoma 0,6%, dan 3,9% pasien mempunyai
jenis lain. 
Kesimpulan: Sebagian besar insidens kanker serviks (76,7%)
berada pada stadium lanjut (≥ stadium IIB). Sebesar 57,8% kasus
terjadi pada usia 45 - 59 tahun. Karsinoma sel skuamosa meru-
pakan tipe histopatologi yang paling sering (70,2%), diikuti ade-
nokarsinoma (15,1%), dan adenoskuamosa (10,2%). Belum efektif-
nya program skrining yang ditujukan untuk mendeteksi dan me-
natalaksana kondisi prekanker merupakan penyebab tingginya in-
sidens kanker serviks pada stadium lanjut.
[Maj Obstet Ginekol Indones 2011; 35-1: 21-4]
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vances in the detection and management, cervical can-
cer continues to be a significant health problem on a
world-wide scale.4
In a developing country like Indonesia, the avail-
ability of limited information on disease incidence is
an impediment to program planning and evaluation
that are required for prevention and control of disease.
The knowledge about the incidence of the disease will
be useful to point the right target for screening. Be-
sides screening, analysis of trends in invasive cervical
cancer incidence may prove useful in order to under-
stand the changing pattern of risk factor exposure in
subsequent generation.
The objective of this study is to have a preview of
the disease in Dr. Cipto Mangunkusumo Hospital, es-
pecially the distribution of age, stage at presentation,
and histopathology of patients presenting with carci-
noma of the cervix, where scarcity of data has caused
hindrance in designing projects for prevention and
early detection of disease. Hence it is of great signifi-
cance to analyze the new trends about clinical features
of cervical cancer in Indonesia.
METHODS
The cross sectional study retrospectively conducted
on 2297 cervical cancer patients registered in Cancer
Registration Information System during a 5-year pe-
riod, starting from January 2006 to December 2010.
Histotype was confirmed by histopathology examina-
tion. The International Federation of Gynecology and
Obstetrics (FIGO) classification was used to stage the
disease. The research data is processed using SPSS
software 14.00.
RESULT
According to data obtained from cancer registration
information system in Dr. Cipto Mangunkusumo Hos-
pital from January 2006 to December 2010 (Table 1),
there were 2297 cases of cervical cancer. Of 2297
patients, the mean age was 51.42 years old (SD 9.694)
with the age range was 21 to 85 years. The highest
incidence was at 50 - 54 years old (20.5%) and 45 -
49 years old (20.3%), and followed by 55 - 59 years
old (17%). This three groups encompassed half of all
cervical cancer cases recorded.
Table 1. Distribution of age groups of cervical cancer in Dr.
Cipto Mangunkusumo Hospital Year 2006 - 2010.
Age Frequency Percent ValidPercent
Cumulative
Percent
20 - 24   6  0.3  0.3  0.3
25 - 29  19  0.8  0.8  1.1
30 - 34  52  2.3  2.3  3.4
35 - 39 158  6.9  6.9 10.2
40 - 44 311 13.5 13.5 23.8
45 - 49 466 20.3 20.3 44.1
50 - 54 471 20.5 20.5 64.6
55 - 59 391 17.0 17.0 81.6
60 - 64 210  9.1  9.1 90.7
65 - 69 123  5.4  5.4 96.1
70 - 74  57  2.5  2.5 98.6
75 - 79  23  1.0  1.0 99.6
80 - 84  10  0.4  0.4 100.0 
Total 2297 100.0 100.0 
One-hundred and thirty-four cases did not mention
the stage of cancer in the system register (Table 2).
While on the remaining cases, stadium IIIb is the
highest incidence at the time of diagnosis (50.2%).
Early stages only consisted 23.3% of the cases.
Table 2. Distribution of cervical cancer stage in Dr. Cipto Ma-
ngunkusumo Hospital Year 2006 - 2010.
Stage Frequency Percent ValidPercent
Cumulative
Percent
IA1   9  0.4  0.4  0.4
IA2   3  0.1  0.1  0.6
IB1 158  6.9  7.3  7.9
IB2 106  4.6  4.9 12.8
IIA 228  9.9 10.5 23.3
IIB 375 16.3 17.3 40.6
IIIA  36  1.6  1.7 42.3
IIIB 1085 47.2 50.2 92.5
IVA  94  4.1  4.3 96.8
IVB  69  3.0  3.2 100.0 
Total 2163 94.2 100.0 
No data 134 5.8
Total 2297 100.0
Table 3. Distribution of cervical cancer histotypes in Dr. Cipto Mangunkusumo Hospital year 2006 - 2010.
Frequency Percent Valid Percent Cumulative Percent
Other (eg. Anaplastic)   73  3.2  3.9  3.9
Squamous Cell Carcinoma 1322 57.6 70.2 74.0
Adenocarcinoma  285 12.4 15.1 89.2
Adenosquamous Carcinoma (Mucoepidermoid)  192  8.4 10.2 99.4
Clear Cell Carcinoma (Mesonephroid Tumor)   12  0.5  0.6 100.0 
Total 1884 82.0 100.0 
No data  413 18.0
Total 2297 100.0 
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There were 413 cases that had no data about the
histopathology. The remaining cases showed that
squamous cell carcinoma was the most frequent type
of cervical cancer histopathology (70.2%). Clear cell
carcinoma was the least one (0.6%).
DISCUSSION
The clinical presentation pattern of cervical cancer
will help us to identify the appropriate age group for
cervical cancer screening.5 In our study, the age
ranged from 21 to 85 years old, with the mean age
of 51.42 years (SD 9.649) and the highest incidence
in the age group of 45 - 59 years. In 2002, other study
in Indonesia showed that the highest incidence was
in the age group of 55 - 64 years and followed by
the age group of 45 - 54 years.6 The comparison of
these two studies showed that there is a little change
in the age of cervical cancer patients. Our study found
that cervical cancer was higher at younger ages com-
pared to the previous study. This might be caused by
screening programs that has been promoted more
broadly than the previous term. The mean age in this
study corresponded to the mean age found by Mis-
saoui et al4 (2010) in Tunisia and Badar et al7 at mos-
lem community. The mean age of those studies were
52.1 and 49.2 years old, respectively.
In the other hand, recently, many studies at devel-
oped countries showed the increase in cervical cancer
incidence at younger age.8-11 Cervical cancer inci-
dence at younger age may be contributed by early
exposure of sexual activity, early menarche, multiple
sex partner, sexual promiscuity, HPV infection, a high
incidence of sexual transmitted disease, smoking, and
oral contraception.12,13 Other factor that contributes
the earlier finding is screening programs in developed
countries which have been carried out sufficiently, al-
lowing early detection of cervical cancer at early
stage.9 A study in Morroco showed the mean age was
44.8 years old.4 England and Wales also reported a
decline cervical cancer incidence in the age group of
45 - 64 years and 55 - 64 years and a significant
increase in younger age groups, 35 - 39 years and 40
- 44 years. Switzerland, another country with a suc-
cessful screening programs, especially at 20 - 44 years
old, reported a decrease in cervical cancer incidence
in 30 - 64 years old group.11
The difference in the mean age and the highest age
group incidence of cervical cancer patients between
our study and studies in countries with sufficient
screening programs showed that the screening pro-
grams in Indonesia have not been conducted suffi-
ciently. The existence of cervical cancer diagnosed in
post-menopausal age showed that cervical cancer
screening should not be stopped in menopausal age.
There was a report that women who are screened
every three years before 50 years, did not develop
cervical cancer, but women who did not undergo
regular screening, may still develop cervical cancer
after the age of 50.14
In our study, 70.2% of cervical cancer patients
were detected at advanced stage. This result relatively
has not changed since previous study carried out in
1997 - 1998 in Dr. Cipto Mangunkusumo Hospital
which stated that 67.5% of cervical cancer patients
came to the hospital at advanced stage.15 This data
showed that the screening programs has not been car-
ried out sufficiently because the majority of cervical
cancer patiens were detected at advanced stage. Our
result were similar to characteristics that were found
in other developing countries. A study in Tunisia4
show-ed 33.6% patients were diagnosed at stage 0 and
1 and 58.2% patients were diagnosed at stage II to
stage IV. In Pakistan7, 33.4% patients were diagnosed
at stage II and 21.5% were diagnosed at stage III. In
countries where screening programs have well deve-
loped, e.g Canada and Scandinavia, cervical cancer
incidence was relative low.16
The incidence of cervical cancer in Dr. Cipto Ma-
ngunkusumo Hospital, that most cases were diag-
nosed in advanced stage, showed the lack of cervical
cancer screening. With screening initiation, the inci-
dence in Indonesia will result in earlier stage during
detection.
From this study, we found squamous cell carcino-
ma (epidermoid) as the most common histopathologic
type of cervical cancer (70.2%), followed by adeno-
carcinoma (15.1%), adenosquamous carcinoma (10.2%),
clear cell carcinoma (0.6%) and other types (3.9%).
The high incidence of squamous cell carcinoma was
consistent with several other studies, for example
Bhurgri et al5 who reported the following: squamous
cell carcinoma in 86.5% patients, adenocarcinoma in
10.9%, and adenosquamous carcinoma in 2.6%. In ad-
dition, a study in Turkey also reported squamous cell
carcinoma (89.1%) as the most common histologic
findings.17 In 1995, Shingelton et al also found a si-
milar result; 83.8% cases of cervical cancer were
squamous cell carcinoma, 12.6% were adenocarci-
noma, and the remaining 3.6% were other cancers.18
In the recent studies, there was a tendency of an
increased proportion of adenocarcinoma incidence
compared to squamous cell carcinoma and cervical
cancer in general.7,10,19-21 Shingleton et al18 reported
an increased frequency of adenocarcinoma among all
types of cervical cancer, from 7% in the period of
1974 - 1978 to 19% in 1979 - 1980. The incidence
of cervical cancer in Dr. Cipto Mangunkusumo Hos-
pital showed a tendency of an increased adenocarci-
noma incidence compared to squamous cell carci-
noma. This probability should be further investigated
in the future.
CONCLUSION
Our study showed that cervical cancer patients were
most commonly diagnosed in the age 45 - 59 years
old, not much different with the peak incidence of the
same age group in other developing countries. The
majority of cervical cancer patients were diagnosed
in late stage, most commonly IIIB. Therefore, this
data shows that the screening program was not con-
ducted effectively and suggests that screening should
not stop at menopausal age. The cervical cancer-
screening program requires adequate financial, struc-
tural, and human resources support. These require-
ments may be a burden to a developing country like
Indonesia.
The higher incidence of adenocarcinoma in our
study compared to studies in other nations should be
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further studied in the future. This is important, con-
sidering the worse prognosis of adenocarcinoma com-
pared to other types of cervical cancer.
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